Clinical implications of quantitative real-time RT-PCR analysis of hTERT gene expression in human gliomas

British Journal of Cancer

Volumn 88, Issue 4, 2003, Pages 516-520

  Tchirkov, A ^a,b   Rolhion, C ^a,c   Kemeny J L ^b   Irthum, B ^b   Puget, S ^b   Khalil, T ^b   Chinot, O ^d   Kwiatkowski, F ^a   Perissel B ^b   Vago, P ^b   Verrelle, P ^a,c  

^a CENTRE JEAN PERRIN   (France)

^b SERVICE DE RHUMATOLOGIE   (France)

^c INSERM   (France)

^d TIMONE HOSPITAL   (France)

Author keywords

Diagnosis; Glioblastoma multiforme; hTERT; Prognosis; Real time PCR

Indexed keywords

MESSENGER RNA; RNA DIRECTED DNA POLYMERASE; TELOMERASE;

ADULT; ANALYTIC METHOD; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; GENE EXPRESSION; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ONCOGENE; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR DIFFERENTIATION;

ADULT; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL ANALYSIS; TELOMERASE; TIME FACTORS;

EID: 0037463232     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600754     Document Type: Article

References (28)

1. Bamber D (1975) The area above the ordinal dominance graph and the area below the receiver operating characteristic graph. J Math Psychol 12: 387-395
2. Bryan TM, Reddel RR (1997) Telomere dynamics and telomerase activity in in vitro immortalised human cells. Eur J Cancer 33: 767-773
3. Buonamici S, Ottaviani E, Testoni N, Montefusco V, Visani G, Bonifazi F, Amabile M, Terragna C, Ruggeri D, Piccaluga PP, Isidori A, Malagola M, Baccarani M, Tura S, Martinelli G (2002) Real-time quantitation of minimal residual disease in inv(16)-positive acute myeloid leukemia may indicate risk for clinical relapse and may identify patients in a curable state. Blood 99: 443-449
4. Chakravarti A, Delaney MA, Noll E, Black PM, Loeffler JS, Muzikansky A, Dyson NJ (2001) Prognostic and pathologic significance of quantitative protein expression profiling in human gliomas. Clin Cancer Res 7: 2387-2395
5. Counter CM, Hirte HW, Bacchetti S, Harley CB (1994) Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci USA 9: 2900-2904
6. DeAngelis LM (2001) Brain tumors. N Engl J Med 344: 114-123
7. Hanley JA, McNeil BJ (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143: 29-36
8. Harada K, Kurisu K, Tahara H, Tahara E, Ide T, Tahara E (2000) Telomerase activity in primary and secondary glioblastomas multiforme as a novel molecular tumor marker. J Neurosurg 93: 618-625
9. Harley CB, Futcher AB, Greider CW (1990) Telomeres shorten during ageing of human fibroblasts. Nature 345: 458-460
10. Hiraga S, Ohnishi T, Izumoto S, Miyahara E, Kanemura Y, Matsumura H, Arita N (1998) Telomerase activity and alterations in telomere length in human brain tumors. Cancer Res 58: 2117-2125
11. Hiyama E, Hiyama K, Yokoyama T, Shay JW (2001) Immunohistochemical detection of telomerase (hTERT) protein in human cancer tissues and a subset of cells in normal tissues. Neoplasia 3: 17-26
12. Huang F, Kanno H, Yamamoto I, Lin Y, Kubota Y (1999) Correlation of clinical features and telomerase activity in human gliomas. J Neuro-oncol 43: 137-142
13. Kaplan E, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481
14. Kleinschmidt-Demasters BK, Evans LC, Bobak JB, Lopez-Uribe D, Hopper D, Shroyer AL, Shroyer KR (2000) Quantitative telomerase expression in glioblastomas shows regional variation and down-regulation with therapy but no correlation with patient outcome. Hum Pathol 31: 905-913
15. Komata T, Kanzawa T, Kondo Y, Kondo S (2002) Telomerase as a therapeutic target for malignant gliomas. Oncogene 21: 656-663
16. Langford LA, Piatyszek MA, Xu R, Schold SC, Shay JW (1995) Telomerase activity in human brain tumours. Lancet 346: 1267-1268
17. Le S, Zhu JJ, Anthony DC, Greider CW, Black PM (1998) Telomerase activity in human gliomas. Neurosurgery 42: 1120-1124
18. Moniotte S, Vaerman JL, Kockx MM, Larrouy D, Langin D, Noirhomme P, Balligand JL (2001) Real-time RT-PCR for the detection of beta-adrenoceptor messenger RNAs in small human endomyocardial biopsies. J Mol Cell Cardiol 33: 2121-2133
19. Morii K, Tanaka R, Onda K, Tsumanuma I, Yoshimura J (1997) Expression of telomerase RNA, telomerase activity, and telomere length in human gliomas. Biochem Biophys Res Commun 239: 830-834
20. Morin GB (1989) The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 59: 521-529
21. Nakatani K, Yoshimi N, Mori H, Yoshimura S, Sakai H, Shinoda J, Sakai N (1997) The significant role of telomerase activity in human brain tumors. Cancer 80: 471-476
22. Pool JC, Andrews LG, Tollefsbol TO (2001) Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT). Gene 269: 1-12
23. Rolhion C, Penault-Llorca F, Chevillard S, Verrelle P, Finat-Duclos F (1999) Quantification of RT-PCR products: assessment of ethidium bromide stained gel analysis in comparison with fluorescent detection using an automated sequencer. Lab Med 30: 419-422
24. Scott JN, Rewcastle NB, Brasher PM, Fulton D, MacKinnon JA, Hamilton M, Cairncross JG, Forsyth P (1999) Which glioblastoma multiforme patient will become a long-term survivor? A population-based study. Ann Neurol 46: 183-188
25. Shay JW, Zou Y, Hiyama E, Wright WE (2001) Telomerase and cancer. Hum Mol Genet 10: 677-685
26. Sugita Y, Nakashima A, Kato S, Sakata K, Morimatsu M, Shigemori M (2000) Telomerase activity in gllomas with the use of non-radioisotopic and semi-quantitative procedure for terminal repeat amplification protocol. Oncol Rep 7: 1087-1092
27. Tchirkov A, Giollant M, Tavernier F, Briançon G, Tournilhac O, Kwiatkowski F, Philippe P, Choufi B, Deméocq F, Travade P, Malet P (1998) Interphase cytogenetics and competitive RT-PCR for residual disease monitoring in patients with chronic myeloid leukemia during interferon-α therapy. Br J Haematol 101: 552-557
28. World Health Organization (2000) WHO Classification Astrocytic tumors. Oligodendroglial tumours and mixed gliomas. In Pathology and Genetics of Tumours of the Nervous System, Kleihues P, Cavenee WK (eds) pp 6-70. Lyon: IARC Press